Literature DB >> 22593801

Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress.

L Alexis Hoeferlin1, Natalia V Oleinik, Natalia I Krupenko, Sergey A Krupenko.   

Abstract

The folate enzyme, FDH (10-formyltetrahydrofolate dehydrogenase, ALDH1L1), a metabolic regulator of proliferation, activates p53-dependent G1 arrest and apoptosis in A549 cells. In the present study, we have demonstrated that FDH-induced apoptosis is abrogated upon siRNA knockdown of the p53 downstream target PUMA. Conversely, siRNA knockdown of p21 eliminated FDH-dependent G1 arrest and resulted in an early apoptosis onset. The acceleration of FDH-dependent apoptosis was even more profound in another cell line, HCT116, in which the p21 gene was silenced through homologous recombination (p21(-/-) cells). In contrast to A549 cells, FDH caused G2 instead of G1 arrest in HCT116 p21(+/+) cells; such an arrest was not seen in p21-deficient (HCT116 p21(-/-)) cells. In agreement with the cell cycle regulatory function of p21, its strong accumulation in nuclei was seen upon FDH expression. Interestingly, our study did not reveal DNA damage upon FDH elevation in either cell line, as judged by comet assay and the evaluation of histone H2AX phosphorylation. In both A549 and HCT116 cell lines, FDH induced a strong decrease in the intracellular ATP pool (2-fold and 30-fold, respectively), an indication of a decrease in de novo purine biosynthesis as we previously reported. The underlying mechanism for the drop in ATP was the strong decrease in intracellular 10-formyltetrahydrofolate, a substrate in two reactions of the de novo purine pathway. Overall, we have demonstrated that p21 can activate G1 or G2 arrest in the absence of DNA damage as a response to metabolite deprivation. In the case of FDH-related metabolic alterations, this response delays apoptosis but is not sufficient to prevent cell death.

Entities:  

Keywords:  ALDH1L1; PUMA; apoptosis; cell cycle arrest; folate metabolism; p21

Year:  2011        PMID: 22593801      PMCID: PMC3352155          DOI: 10.1177/1947601911432495

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  71 in total

1.  A non-enzymatic p21 protein inhibitor of stress-activated protein kinases.

Authors:  J Shim; H Lee; J Park; H Kim; E J Choi
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

2.  Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells.

Authors:  J Wendt; S Radetzki; C von Haefen; P G Hemmati; D Güner; K Schulze-Osthoff; B Dörken; P T Daniel
Journal:  Oncogene       Date:  2006-02-16       Impact factor: 9.867

3.  Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage.

Authors:  B C Blount; M M Mack; C M Wehr; J T MacGregor; R A Hiatt; G Wang; S N Wickramasinghe; R B Everson; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

4.  Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway.

Authors:  Sungwoo Lee; David M Helfman
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

5.  Intracellular localization of the cyclin-dependent kinase inhibitor p21CDKN1A-GFP fusion protein during cell cycle arrest.

Authors:  Ornella Cazzalini; Paola Perucca; Federica Valsecchi; Lucia A Stivala; Livia Bianchi; Vanio Vannini; Ennio Prosperi
Journal:  Histochem Cell Biol       Date:  2004-05-07       Impact factor: 4.304

6.  CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells.

Authors:  Koichi Takagi; Yoshihiro Sowa; Ozgur Muhammer Cevik; Ryoko Nakanishi; Toshiyuki Sakai
Journal:  Int J Oncol       Date:  2008-05       Impact factor: 5.650

7.  P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells.

Authors:  Valérie Chopin; Robert-Alain Toillon; Nathalie Jouy; Xuefen Le Bourhis
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

8.  Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP.

Authors:  A Suzuki; Y Tsutomi; K Akahane; T Araki; M Miura
Journal:  Oncogene       Date:  1998-08-27       Impact factor: 9.867

9.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

10.  Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously.

Authors:  D G Priest; J C Schmitz; M A Bunni; R K Stuart
Journal:  J Natl Cancer Inst       Date:  1991-12-18       Impact factor: 13.506

View more
  29 in total

Review 1.  Functional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration.

Authors:  Nilkantha Sen
Journal:  J Mol Biol       Date:  2016-12-21       Impact factor: 5.469

2.  Mild electrical stimulation at 0.1-ms pulse width induces p53 protein phosphorylation and G2 arrest in human epithelial cells.

Authors:  Ryosuke Fukuda; Mary Ann Suico; Kosuke Koyama; Kohei Omachi; Yukari Kai; Shingo Matsuyama; Kazunori Mitsutake; Manabu Taura; Saori Morino-Koga; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

3.  In vitro toxicological evaluation of ethyl carbamate in human HepG2 cells.

Authors:  Xia Cui; Jiayi Wang; Nannan Qiu; Yongning Wu
Journal:  Toxicol Res (Camb)       Date:  2016-02-08       Impact factor: 3.524

4.  Involvement of CDKN1A (p21) in cellular senescence in response to heat and irradiation stress during preimplantation development.

Authors:  Sun-A Ock; Jason G Knott; Inchul Choi
Journal:  Cell Stress Chaperones       Date:  2020-04-06       Impact factor: 3.667

5.  CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress.

Authors:  Baharan Fekry; Kristen A Jeffries; Amin Esmaeilniakooshkghazi; Besim Ogretmen; Sergey A Krupenko; Natalia I Krupenko
Journal:  J Biol Chem       Date:  2016-06-14       Impact factor: 5.157

Review 6.  Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression.

Authors:  Sergey A Krupenko; Natalia I Krupenko
Journal:  Chem Biol Interact       Date:  2019-02-20       Impact factor: 5.192

7.  Mdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells.

Authors:  Kyle P Feeley; Clare M Adams; Ramkrishna Mitra; Christine M Eischen
Journal:  Cancer Res       Date:  2017-06-02       Impact factor: 12.701

8.  ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells.

Authors:  Jingru Li; Yicheng Chen; Jiali Wan; Xin Liu; Chunrong Yu; Wenhua Li
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

9.  Rho GTPases RhoA and Rac1 mediate effects of dietary folate on metastatic potential of A549 cancer cells through the control of cofilin phosphorylation.

Authors:  Natalia V Oleinik; Kristi L Helke; Emily Kistner-Griffin; Natalia I Krupenko; Sergey A Krupenko
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

10.  Identification of a Small Molecule That Overcomes HdmX-Mediated Suppression of p53.

Authors:  Goutam Karan; Huaiyu Wang; Amit Chakrabarti; Sukanya Karan; Zhigang Liu; Zhiqiang Xia; Mahesh Gundluru; Stephen Moreton; Yogen Saunthararajah; Mark W Jackson; Mukesh K Agarwal; David N Wald
Journal:  Mol Cancer Ther       Date:  2016-02-16       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.